Systemic Therapy for Mucosal, Acral and Uveal Melanoma View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2019-02-26

AUTHORS

Suthee Rapisuwon , Yong Qin , Jason Roszik , Fernando Carapeto , Sapna Patel , Richard D. Carvajal

ABSTRACT

Melanoma is a disease that is remarkably heterogeneous. Even cutaneous melanoma, the most common melanoma subtype, is characterized by important biological and clinical differences between disease arising from nonchronically sun-exposed and chronically sun-exposed skin. Acral melanoma, melanomas which arise from skin on the palms of the hands, soles of the feet, or beneath the nails of the fingers or toes, and extracutaneous melanomas, such as those arising from the mucosal surfaces of the body and from the uveal tract of the eye, are uncommon melanoma subtypes also characterized by biological and clinical characteristics distinct from non-acral cutaneous melanoma and distinct from one another. These melanoma subtypes share a more aggressive natural history as well as a lack of association with ultraviolet radiation when compared with non-acral cutaneous disease.Because of the rarity of acral and extracutaneous melanomas, robust clinical trial data are relatively limited when compared with that available for cutaneous melanoma, and management recommendations are frequently based upon consensus opinion and are often extrapolated from the experience in cutaneous melanoma. Importantly, the molecular and immunological differences between non-acral cutaneous melanoma, acral melanoma, mucosal melanoma, and uveal melanoma have critical implications for the appropriate use of systemic therapy in both the advanced disease and adjuvant settings.In this chapter, we review the clinical, molecular, and immunological characteristics of acral, mucosal, and uveal melanoma in the context of systemic therapy, including molecularly targeted and immunological therapies. We discuss the use of systemic therapy in both the advanced disease setting as well as the adjuvant setting. Finally, we review emerging data on new therapeutic options and the use of systemic therapy in additional clinical settings such as in the neoadjuvant setting. More... »

PAGES

1-37

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-319-46029-1_62-1

DOI

http://dx.doi.org/10.1007/978-3-319-46029-1_62-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1117711574


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Division of Hematology/Oncology, Georgetown University; Lombardi Comprehensive Cancer Center, Washington, DC, USA", 
          "id": "http://www.grid.ac/institutes/grid.516085.f", 
          "name": [
            "Department of Medicine, Division of Hematology/Oncology, Georgetown University; Lombardi Comprehensive Cancer Center, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rapisuwon", 
        "givenName": "Suthee", 
        "id": "sg:person.01155613526.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155613526.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Qin", 
        "givenName": "Yong", 
        "id": "sg:person.01116767046.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116767046.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roszik", 
        "givenName": "Jason", 
        "id": "sg:person.015671353647.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015671353647.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carapeto", 
        "givenName": "Fernando", 
        "id": "sg:person.015546007254.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015546007254.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Patel", 
        "givenName": "Sapna", 
        "id": "sg:person.014634030547.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014634030547.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center; Herbert Irving Comprehensive Cancer Center, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.516091.a", 
          "name": [
            "Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center; Herbert Irving Comprehensive Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carvajal", 
        "givenName": "Richard D.", 
        "id": "sg:person.0726366600.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726366600.25"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2019-02-26", 
    "datePublishedReg": "2019-02-26", 
    "description": "Abstract\nMelanoma is a disease that is remarkably heterogeneous. Even cutaneous melanoma, the most common melanoma subtype, is characterized by important biological and clinical differences between disease arising from nonchronically sun-exposed and chronically sun-exposed skin. Acral melanoma, melanomas which arise from skin on the palms of the hands, soles of the feet, or beneath the nails of the fingers or toes, and extracutaneous melanomas, such as those arising from the mucosal surfaces of the body and from the uveal tract of the eye, are uncommon melanoma subtypes also characterized by biological and clinical characteristics distinct from non-acral cutaneous melanoma and distinct from one another. These melanoma subtypes share a more aggressive natural history as well as a lack of association with ultraviolet radiation when compared with non-acral cutaneous disease.Because of the rarity of acral and extracutaneous melanomas, robust clinical trial data are relatively limited when compared with that available for cutaneous melanoma, and management recommendations are frequently based upon consensus opinion and are often extrapolated from the experience in cutaneous melanoma. Importantly, the molecular and immunological differences between non-acral cutaneous melanoma, acral melanoma, mucosal melanoma, and uveal melanoma have critical implications for the appropriate use of systemic therapy in both the advanced disease and adjuvant settings.In this chapter, we review the clinical, molecular, and immunological characteristics of acral, mucosal, and uveal melanoma in the context of systemic therapy, including molecularly targeted and immunological therapies. We discuss the use of systemic therapy in both the advanced disease setting as well as the adjuvant setting. Finally, we review emerging data on new therapeutic options and the use of systemic therapy in additional clinical settings such as in the neoadjuvant setting.", 
    "editor": [
      {
        "familyName": "Balch", 
        "givenName": "Charles", 
        "type": "Person"
      }, 
      {
        "familyName": "Gershenwald", 
        "givenName": "Jeffrey", 
        "type": "Person"
      }, 
      {
        "familyName": "Thompson", 
        "givenName": "John", 
        "type": "Person"
      }, 
      {
        "familyName": "Atkins", 
        "givenName": "Michael", 
        "type": "Person"
      }, 
      {
        "familyName": "Kirkwood", 
        "givenName": "John", 
        "type": "Person"
      }, 
      {
        "familyName": "Kefford", 
        "givenName": "Richard", 
        "type": "Person"
      }, 
      {
        "familyName": "Sober", 
        "givenName": "Arthur", 
        "type": "Person"
      }, 
      {
        "familyName": "Halpern", 
        "givenName": "Allan", 
        "type": "Person"
      }, 
      {
        "familyName": "Garbe", 
        "givenName": "Claus", 
        "type": "Person"
      }, 
      {
        "familyName": "Scolyer", 
        "givenName": "Richard", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-319-46029-1_62-1", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-319-46029-1", 
        "978-3-319-46029-1"
      ], 
      "name": "Cutaneous Melanoma", 
      "type": "Book"
    }, 
    "keywords": [
      "non-acral cutaneous melanoma", 
      "systemic therapy", 
      "cutaneous melanoma", 
      "melanoma subtypes", 
      "uveal melanoma", 
      "adjuvant setting", 
      "advanced disease", 
      "extracutaneous melanomas", 
      "acral melanoma", 
      "robust clinical trial data", 
      "common melanoma subtype", 
      "additional clinical settings", 
      "aggressive natural history", 
      "new therapeutic options", 
      "clinical trial data", 
      "lack of association", 
      "neoadjuvant setting", 
      "clinical characteristics", 
      "uveal tract", 
      "mucosal melanoma", 
      "immunological therapies", 
      "therapeutic options", 
      "clinical differences", 
      "cutaneous disease", 
      "immunological characteristics", 
      "mucosal surfaces", 
      "immunological differences", 
      "trial data", 
      "therapy", 
      "melanoma", 
      "natural history", 
      "clinical setting", 
      "consensus opinion", 
      "disease", 
      "subtypes", 
      "appropriate use", 
      "skin", 
      "management recommendations", 
      "setting", 
      "mucosal", 
      "acral", 
      "tract", 
      "nail", 
      "ultraviolet radiation", 
      "differences", 
      "eyes", 
      "rarity", 
      "association", 
      "foot", 
      "use", 
      "toe", 
      "options", 
      "finger", 
      "critical implications", 
      "data", 
      "recommendations", 
      "history", 
      "lack", 
      "experience", 
      "body", 
      "characteristics", 
      "palm", 
      "hand", 
      "opinion", 
      "implications", 
      "radiation", 
      "chapter", 
      "sol", 
      "context", 
      "surface"
    ], 
    "name": "Systemic Therapy for Mucosal, Acral and Uveal Melanoma", 
    "pagination": "1-37", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1117711574"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-319-46029-1_62-1"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-319-46029-1_62-1", 
      "https://app.dimensions.ai/details/publication/pub.1117711574"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-12-01T06:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/chapter/chapter_219.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-319-46029-1_62-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-46029-1_62-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-46029-1_62-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-46029-1_62-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-46029-1_62-1'


 

This table displays all metadata directly associated to this object as RDF triples.

214 TRIPLES      22 PREDICATES      93 URIs      86 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-319-46029-1_62-1 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Ncb98b4113c0e41c0908879245d40924c
4 schema:datePublished 2019-02-26
5 schema:datePublishedReg 2019-02-26
6 schema:description Abstract Melanoma is a disease that is remarkably heterogeneous. Even cutaneous melanoma, the most common melanoma subtype, is characterized by important biological and clinical differences between disease arising from nonchronically sun-exposed and chronically sun-exposed skin. Acral melanoma, melanomas which arise from skin on the palms of the hands, soles of the feet, or beneath the nails of the fingers or toes, and extracutaneous melanomas, such as those arising from the mucosal surfaces of the body and from the uveal tract of the eye, are uncommon melanoma subtypes also characterized by biological and clinical characteristics distinct from non-acral cutaneous melanoma and distinct from one another. These melanoma subtypes share a more aggressive natural history as well as a lack of association with ultraviolet radiation when compared with non-acral cutaneous disease.Because of the rarity of acral and extracutaneous melanomas, robust clinical trial data are relatively limited when compared with that available for cutaneous melanoma, and management recommendations are frequently based upon consensus opinion and are often extrapolated from the experience in cutaneous melanoma. Importantly, the molecular and immunological differences between non-acral cutaneous melanoma, acral melanoma, mucosal melanoma, and uveal melanoma have critical implications for the appropriate use of systemic therapy in both the advanced disease and adjuvant settings.In this chapter, we review the clinical, molecular, and immunological characteristics of acral, mucosal, and uveal melanoma in the context of systemic therapy, including molecularly targeted and immunological therapies. We discuss the use of systemic therapy in both the advanced disease setting as well as the adjuvant setting. Finally, we review emerging data on new therapeutic options and the use of systemic therapy in additional clinical settings such as in the neoadjuvant setting.
7 schema:editor N2f163afa67d849b49bc4d12e87de889d
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf Nf449fbe4d150431a82119b31740d3643
11 schema:keywords acral
12 acral melanoma
13 additional clinical settings
14 adjuvant setting
15 advanced disease
16 aggressive natural history
17 appropriate use
18 association
19 body
20 chapter
21 characteristics
22 clinical characteristics
23 clinical differences
24 clinical setting
25 clinical trial data
26 common melanoma subtype
27 consensus opinion
28 context
29 critical implications
30 cutaneous disease
31 cutaneous melanoma
32 data
33 differences
34 disease
35 experience
36 extracutaneous melanomas
37 eyes
38 finger
39 foot
40 hand
41 history
42 immunological characteristics
43 immunological differences
44 immunological therapies
45 implications
46 lack
47 lack of association
48 management recommendations
49 melanoma
50 melanoma subtypes
51 mucosal
52 mucosal melanoma
53 mucosal surfaces
54 nail
55 natural history
56 neoadjuvant setting
57 new therapeutic options
58 non-acral cutaneous melanoma
59 opinion
60 options
61 palm
62 radiation
63 rarity
64 recommendations
65 robust clinical trial data
66 setting
67 skin
68 sol
69 subtypes
70 surface
71 systemic therapy
72 therapeutic options
73 therapy
74 toe
75 tract
76 trial data
77 ultraviolet radiation
78 use
79 uveal melanoma
80 uveal tract
81 schema:name Systemic Therapy for Mucosal, Acral and Uveal Melanoma
82 schema:pagination 1-37
83 schema:productId N8757973e90674856adb6e44901102cd3
84 N9d0a2928a2e041cf8d019d37cde402e6
85 schema:publisher Nf8090b5b2cf346ca9409de3e30a06b8e
86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1117711574
87 https://doi.org/10.1007/978-3-319-46029-1_62-1
88 schema:sdDatePublished 2022-12-01T06:48
89 schema:sdLicense https://scigraph.springernature.com/explorer/license/
90 schema:sdPublisher Need840b6320940918222eba04adf41e1
91 schema:url https://doi.org/10.1007/978-3-319-46029-1_62-1
92 sgo:license sg:explorer/license/
93 sgo:sdDataset chapters
94 rdf:type schema:Chapter
95 N0d082fdd1f08431595ca7e05bc6bcd12 schema:familyName Balch
96 schema:givenName Charles
97 rdf:type schema:Person
98 N106c93263e7442b584ca4e16e4311fda rdf:first sg:person.015671353647.55
99 rdf:rest N4f97c9a9a2484d2fb5e91d81fa6fbcbb
100 N25ed834988d54172b46f88c50f916ff4 schema:familyName Kirkwood
101 schema:givenName John
102 rdf:type schema:Person
103 N2b4501d70b2c43d29150e99fa0ce6af5 schema:familyName Gershenwald
104 schema:givenName Jeffrey
105 rdf:type schema:Person
106 N2f163afa67d849b49bc4d12e87de889d rdf:first N0d082fdd1f08431595ca7e05bc6bcd12
107 rdf:rest Nad073a0706f04aee811fd26539581be0
108 N30df2667bba44a6f817cd4a4dd3ff79a rdf:first N4b44eeff2f0b4016ae44ac19bccaa434
109 rdf:rest Ne6e9766180c64511be48d3f7aeb175ff
110 N45a923a447dc4161a56d177efa2ca152 rdf:first N561a93fbd63b4ddab5db4bfade569386
111 rdf:rest N30df2667bba44a6f817cd4a4dd3ff79a
112 N4a5531df83f44bedb9e2b02bf6eec955 rdf:first Nc93f875b559440be8155b3e0aa6081f4
113 rdf:rest rdf:nil
114 N4b44eeff2f0b4016ae44ac19bccaa434 schema:familyName Sober
115 schema:givenName Arthur
116 rdf:type schema:Person
117 N4f97c9a9a2484d2fb5e91d81fa6fbcbb rdf:first sg:person.015546007254.28
118 rdf:rest N8f543b7670684af1bbda1bf7ba3cadea
119 N561a93fbd63b4ddab5db4bfade569386 schema:familyName Kefford
120 schema:givenName Richard
121 rdf:type schema:Person
122 N7abd0465bd894446adbc8aa7fd421660 schema:familyName Thompson
123 schema:givenName John
124 rdf:type schema:Person
125 N8757973e90674856adb6e44901102cd3 schema:name doi
126 schema:value 10.1007/978-3-319-46029-1_62-1
127 rdf:type schema:PropertyValue
128 N8f543b7670684af1bbda1bf7ba3cadea rdf:first sg:person.014634030547.08
129 rdf:rest Nb30a9d6c19a24cd4addc673b976cd0c8
130 N912f939e656146b58a11459e135e86db rdf:first Nf16e86a4facb47e4ac485463cb1336df
131 rdf:rest N4a5531df83f44bedb9e2b02bf6eec955
132 N9bd7d1399d6a4578beb1adbeaaddc96a schema:familyName Halpern
133 schema:givenName Allan
134 rdf:type schema:Person
135 N9d0a2928a2e041cf8d019d37cde402e6 schema:name dimensions_id
136 schema:value pub.1117711574
137 rdf:type schema:PropertyValue
138 Nad073a0706f04aee811fd26539581be0 rdf:first N2b4501d70b2c43d29150e99fa0ce6af5
139 rdf:rest Nd426dbb5fdfd4df5869324c4e37d06ce
140 Nafc3cfb27476410ba16531ad64a817aa rdf:first Nf8c91cad91b9435baf8af974f09bbfc4
141 rdf:rest Nc347a5ecd3db456da815e0fb17f548ec
142 Nb30a9d6c19a24cd4addc673b976cd0c8 rdf:first sg:person.0726366600.25
143 rdf:rest rdf:nil
144 Nc347a5ecd3db456da815e0fb17f548ec rdf:first N25ed834988d54172b46f88c50f916ff4
145 rdf:rest N45a923a447dc4161a56d177efa2ca152
146 Nc93f875b559440be8155b3e0aa6081f4 schema:familyName Scolyer
147 schema:givenName Richard
148 rdf:type schema:Person
149 Ncb98b4113c0e41c0908879245d40924c rdf:first sg:person.01155613526.20
150 rdf:rest Ne998712624994d16a8dd66fd8833d8f3
151 Nd426dbb5fdfd4df5869324c4e37d06ce rdf:first N7abd0465bd894446adbc8aa7fd421660
152 rdf:rest Nafc3cfb27476410ba16531ad64a817aa
153 Ne6e9766180c64511be48d3f7aeb175ff rdf:first N9bd7d1399d6a4578beb1adbeaaddc96a
154 rdf:rest N912f939e656146b58a11459e135e86db
155 Ne998712624994d16a8dd66fd8833d8f3 rdf:first sg:person.01116767046.03
156 rdf:rest N106c93263e7442b584ca4e16e4311fda
157 Need840b6320940918222eba04adf41e1 schema:name Springer Nature - SN SciGraph project
158 rdf:type schema:Organization
159 Nf16e86a4facb47e4ac485463cb1336df schema:familyName Garbe
160 schema:givenName Claus
161 rdf:type schema:Person
162 Nf449fbe4d150431a82119b31740d3643 schema:isbn 978-3-319-46029-1
163 schema:name Cutaneous Melanoma
164 rdf:type schema:Book
165 Nf8090b5b2cf346ca9409de3e30a06b8e schema:name Springer Nature
166 rdf:type schema:Organisation
167 Nf8c91cad91b9435baf8af974f09bbfc4 schema:familyName Atkins
168 schema:givenName Michael
169 rdf:type schema:Person
170 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
171 schema:name Medical and Health Sciences
172 rdf:type schema:DefinedTerm
173 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
174 schema:name Oncology and Carcinogenesis
175 rdf:type schema:DefinedTerm
176 sg:person.01116767046.03 schema:affiliation grid-institutes:grid.240145.6
177 schema:familyName Qin
178 schema:givenName Yong
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116767046.03
180 rdf:type schema:Person
181 sg:person.01155613526.20 schema:affiliation grid-institutes:grid.516085.f
182 schema:familyName Rapisuwon
183 schema:givenName Suthee
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155613526.20
185 rdf:type schema:Person
186 sg:person.014634030547.08 schema:affiliation grid-institutes:grid.240145.6
187 schema:familyName Patel
188 schema:givenName Sapna
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014634030547.08
190 rdf:type schema:Person
191 sg:person.015546007254.28 schema:affiliation grid-institutes:grid.240145.6
192 schema:familyName Carapeto
193 schema:givenName Fernando
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015546007254.28
195 rdf:type schema:Person
196 sg:person.015671353647.55 schema:affiliation grid-institutes:grid.240145.6
197 schema:familyName Roszik
198 schema:givenName Jason
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015671353647.55
200 rdf:type schema:Person
201 sg:person.0726366600.25 schema:affiliation grid-institutes:grid.516091.a
202 schema:familyName Carvajal
203 schema:givenName Richard D.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726366600.25
205 rdf:type schema:Person
206 grid-institutes:grid.240145.6 schema:alternateName Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
207 schema:name Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
208 rdf:type schema:Organization
209 grid-institutes:grid.516085.f schema:alternateName Department of Medicine, Division of Hematology/Oncology, Georgetown University; Lombardi Comprehensive Cancer Center, Washington, DC, USA
210 schema:name Department of Medicine, Division of Hematology/Oncology, Georgetown University; Lombardi Comprehensive Cancer Center, Washington, DC, USA
211 rdf:type schema:Organization
212 grid-institutes:grid.516091.a schema:alternateName Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center; Herbert Irving Comprehensive Cancer Center, New York, NY, USA
213 schema:name Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center; Herbert Irving Comprehensive Cancer Center, New York, NY, USA
214 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...